癌细胞通过细胞和水平基因转移获得免疫表面蛋白质
bioRxiv : the preprint server for biology
|August 30, 2024
概括
细胞碎片的转移,通过转移免疫标记物和DNA来改变癌细胞. 这种横向的基因转移产生了融合表型,影响瘤发育和细胞癌的免疫治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 细胞膜碎片在细胞之间转移,是瘤微环境中鲜为人知的过程.
- 免疫细胞将膜结合蛋白转移到癌细胞的功能后果仍然不清楚.
研究的目的:
- 为了研究人类清晰细胞癌中细胞瘤的现象.
- 为了确定热细胞化是否改变瘤细胞蛋白质表达和遗传构成.
主要方法:
- 在新鲜脏瘤上进行流细胞计,以检测癌细胞上的淋巴细胞标记物.
- 免疫光检测以确认淋巴细胞标记物与脏瘤标记物 (CAIX) 的同位化.
- RNA分析以评估瘤细胞中基因表达的变化后的trogocytosis.
- 对染色体DNA从免疫细胞转移到瘤细胞的分析.
主要成果:
- 清细胞癌的细胞始终表达淋巴细胞标记物 (CD45,CD56,CD14,CD16).
- RNA分析揭示了瘤细胞中免疫相关基因的上调.
- 观察到染色体DNA从免疫细胞转移到瘤细胞的证据.
- 这种横向基因转移导致了融合表型,表达了免疫和癌症特异性蛋白质.
结论:
- 巨细胞形成提供了一种改变瘤细胞蛋白表达和功能的新机制.
- 横向的基因转移在细胞分裂过程中可以导致混合免疫癌细胞表型.
- 了解囊细胞分裂为瘤发育提供了新的见解,并为癌症免疫疗法和生物标志物提供了潜在的标.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


